Mark Dunphy

3.5k total citations
55 papers, 1.8k citations indexed

About

Mark Dunphy is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mark Dunphy has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Mark Dunphy's work include Medical Imaging Techniques and Applications (19 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Mark Dunphy is often cited by papers focused on Medical Imaging Techniques and Applications (19 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Mark Dunphy collaborates with scholars based in United States, Germany and Japan. Mark Dunphy's co-authors include Jason S. Lewis, H. William Strausś, Steven M. Larson, Alvin H. Freiman, Sriram Venneti, Pat Zanzonico, Andreas Rimner, Michelle M. Kim, Abhijit Parolia and Wolfgang Weber and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Mark Dunphy

51 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Dunphy United States 21 782 576 503 412 321 55 1.8k
Johannes Czernin United States 19 1.1k 1.4× 663 1.2× 513 1.0× 432 1.0× 477 1.5× 50 2.1k
Songji Zhao Japan 24 661 0.8× 295 0.5× 638 1.3× 495 1.2× 225 0.7× 94 1.8k
Mary Sproull United States 17 445 0.6× 394 0.7× 678 1.3× 247 0.6× 402 1.3× 53 1.4k
Sang Moo Lim South Korea 27 1.2k 1.5× 681 1.2× 337 0.7× 233 0.6× 405 1.3× 160 2.3k
Eric Hau Australia 16 286 0.4× 385 0.7× 428 0.9× 478 1.2× 324 1.0× 54 1.3k
Christof Seidl Germany 26 964 1.2× 557 1.0× 365 0.7× 186 0.5× 399 1.2× 59 1.6k
Mohamed E. Abazeed United States 20 354 0.5× 474 0.8× 565 1.1× 449 1.1× 355 1.1× 67 1.6k
Albert van der Kogel Netherlands 15 604 0.8× 496 0.9× 386 0.8× 438 1.1× 277 0.9× 27 1.5k
Anne E. Kiltie United Kingdom 32 384 0.5× 495 0.9× 1.3k 2.5× 450 1.1× 571 1.8× 78 2.5k
Laura Kenny United Kingdom 22 1.0k 1.3× 407 0.7× 434 0.9× 369 0.9× 456 1.4× 52 1.8k

Countries citing papers authored by Mark Dunphy

Since Specialization
Citations

This map shows the geographic impact of Mark Dunphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dunphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dunphy more than expected).

Fields of papers citing papers by Mark Dunphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dunphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dunphy. The network helps show where Mark Dunphy may publish in the future.

Co-authorship network of co-authors of Mark Dunphy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Dunphy. A scholar is included among the top collaborators of Mark Dunphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Dunphy. Mark Dunphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maxwell, Aaron, Juan C. Camacho, Amy R. Deipolyi, et al.. (2022). Optimizing 90Y Particle Density Improves Outcomes After Radioembolization. CardioVascular and Interventional Radiology. 45(7). 958–969. 16 indexed citations
2.
Young, Robert J., Paula Demétrio De Souza França, Giacomo Pirovano, et al.. (2020). Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR. Neuro-Oncology Advances. 2(1). vdaa119–vdaa119. 26 indexed citations
3.
Graham, Maya Srikanth, Simone Krebs, Tejus Bale, et al.. (2020). Value of [18F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab. Neuro-Oncology Advances. 2(1). vdaa050–vdaa050. 6 indexed citations
4.
Schöder, Heiko, Paula Demétrio De Souza França, Reiko Nakajima, et al.. (2020). Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer. Clinical Cancer Research. 26(13). 3110–3116. 48 indexed citations
5.
Riess, Jonathan W., Paul Frankel, David B. Shackelford, et al.. (2020). Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design. Clinical Lung Cancer. 22(1). 67–70. 36 indexed citations
6.
Michaud, Laure, Bradley J. Beattie, Tim Akhurst, et al.. (2019). 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors. European Journal of Nuclear Medicine and Molecular Imaging. 47(6). 1353–1367. 40 indexed citations
7.
Grkovski, Milan, Reema Goel, Simone Krebs, et al.. (2019). Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer. Journal of Nuclear Medicine. 61(3). 357–366. 25 indexed citations
8.
Sawan, Peter, Heiko Schöder, Connie Lee Batlevi, et al.. (2017). Specialized second-opinion radiology review of PET/CT examinations for patients with diffuse large B-cell lymphoma impacts patient care and management. Medicine. 96(51). e9411–e9411. 6 indexed citations
9.
Kim, Michelle M., Abhijit Parolia, Mark Dunphy, & Sriram Venneti. (2016). Non-invasive metabolic imaging of brain tumours in the era of precision medicine. Nature Reviews Clinical Oncology. 13(12). 725–739. 91 indexed citations
10.
Dunphy, Mark, Amanda Foster, Kaitlin M. Woo, et al.. (2015). Prognostic Value of Preradiotherapy 18F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer. Clinical Lung Cancer. 17(3). 184–188. 17 indexed citations
11.
Jhaveri, Komal, Stefan O. Ochiana, Mark Dunphy, et al.. (2014). Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions. Expert Opinion on Investigational Drugs. 23(5). 611–628. 131 indexed citations
12.
Dunphy, Mark, Gabriela Chiosis, Bradley J. Beattie, et al.. (2013). Progress in first-in-human trial of Hsp90-targeted PET imaging in cancer patients. 54(1). 279–279. 3 indexed citations
13.
Cuaron, John, Mark Dunphy, & Andreas Rimner. (2013). Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer. Frontiers in Oncology. 2. 208–208. 64 indexed citations
14.
Kadota, Kyuichi, Christos Colovos, Kei Suzuki, et al.. (2012). FDG-PET SUVmax Combined with IASLC/ATS/ERS Histologic Classification Improves the Prognostic Stratification of Patients with Stage I Lung Adenocarcinoma. Annals of Surgical Oncology. 19(11). 3598–3605. 83 indexed citations
15.
Kadota, Kyuichi, Stefan S. Kachala, Jun‐ichi Nitadori, et al.. (2012). High SUVmax on FDG-PET Indicates Pleomorphic Subtype in Epithelioid Malignant Pleural Mesothelioma: Supportive Evidence to Reclassify Pleomorphic as Nonepithelioid Histology. Journal of Thoracic Oncology. 7(7). 1192–1197. 31 indexed citations
16.
Dunphy, Mark, et al.. (2011). 18F-2-Deoxy-d-Glucose Positron Emission Tomography-Computed Tomography in Lung Cancer. Seminars in Roentgenology. 46(3). 208–223. 1 indexed citations
17.
Dunphy, Mark, Pat Zanzonico, Darren R. Veach, et al.. (2010). Dosimetry of 18F-Labeled Tyrosine Kinase Inhibitor SKI-249380, a Dasatinib-Tracer for PET Imaging. Molecular Imaging and Biology. 14(1). 25–31. 10 indexed citations
18.
Dunphy, Mark, David Entenberg, Ricardo Toledo‐Crow, & Steven M. Larson. (2009). In vivo microcartography and subcellular imaging of tumor angiogenesis: A novel platform for translational angiogenesis research. Microvascular Research. 78(1). 51–56. 16 indexed citations
19.
Dunphy, Mark & H. William Strausś. (2008). Molecular imaging of atherosclerosis. Current Cardiology Reports. 10(2). 121–127. 5 indexed citations
20.
Zanzonico, Pat, Mark Dunphy, Gregor J. Förster, et al.. (2004). 1094-152 Suppression of physiological myocardial fluorodeoxyglucose uptake. Journal of the American College of Cardiology. 43(5). A337–A337. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Czernin Breakdown of academic impact, for papers by Songji Zhao Breakdown of academic impact, for papers by Mary Sproull Breakdown of academic impact, for papers by Sang Moo Lim Breakdown of academic impact, for papers by Eric Hau Breakdown of academic impact, for papers by Christof Seidl Breakdown of academic impact, for papers by Mohamed E. Abazeed Breakdown of academic impact, for papers by Albert van der Kogel Breakdown of academic impact, for papers by Anne E. Kiltie Breakdown of academic impact, for papers by Laura Kenny
Rankless by CCL
2026